A carregar...
The Fallacy of Average: How Using HbA(1c) Alone to Assess Glycemic Control Can Be Misleading
HbA(1c) is a valuable metric for comparing treatment groups in a randomized trial, for assessing glycemic trends in a population over time, or for cross-sectional comparisons of glycemic control in different populations. However, what is not widely appreciated is that HbA(1c) may not be a good indic...
Na minha lista:
| Publicado no: | Diabetes Care |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5521971/ https://ncbi.nlm.nih.gov/pubmed/28733374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-0636 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|